Autolus Therapeutics Q2 EPS $(0.22) Misses $(0.19) Estimate, Company Exits Quarter With Cash & Equivalents Worth $705.9M
Autolus Therapeutics Q2 EPS $(0.22) Misses $(0.19) Estimate, Company Exits Quarter With Cash & Equivalents Worth $705.9M
autolus therapeutics Q2每股收益爲$(0.22)，低於預估$(0.19)，公司季末現金及等價物價值爲$705.9M。
Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 15.38 percent increase over losses of $(0.26) per share from the same period last year.
Autolus Therapeutics (納斯達克：autolus therapeutics)報告每股虧損$(0.22)，未達到分析師共識預期的$(0.19)，下降了15.79％。這比去年同期每股虧損$(0.26)增加了15.38％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間